INCY - Incyte Corporation
NASDAQ
->
Healthcare
->
Biotechnology
Wilmington,
United States
Type: Equity
INCY price evolution
INCY
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $988.92 | $3347.83 | $3215.22 | |
| Short term investments | $532.08 | $504.48 | $442.67 | |
| Net receivables | $758.45 | $739.05 | $745.53 | $743.56 |
| Inventory | $70.44 | $355.97 | $63.64 | $269.94 |
| Total current assets | $2808.71 | $2567.09 | $4849.09 | $4645.4 |
| Long term investments | $29.67 | $287.66 | $187.72 | |
| Property, plant & equipment | $798.17 | $787.54 | $745.53 | $777.05 |
| Goodwill & intangible assets | $269.13 | $273.43 | $279.14 | |
| Total noncurrent assets | $2094.72 | $2286.51 | $2136.7 | |
| Total investments | $561.75 | $792.15 | $630.38 | |
| Total assets | $5012.43 | $4661.8 | $7135.6 | $6782.11 |
| Current liabilities | ||||
| Accounts payable | $178.71 | $148.17 | $164.24 | $109.6 |
| Deferred revenue | ||||
| Short long term debt | $3.87 | $3.68 | $3.44 | |
| Total current liabilities | $1501.65 | $1337.06 | $1396.45 | $1240.38 |
| Long term debt | $28.22 | $28.75 | $28.93 | $29.16 |
| Total noncurrent liabilities | $327.69 | $344.88 | $351.89 | |
| Total debt | $32.62 | $32.61 | $32.6 | |
| Total liabilities | $1841.21 | $1664.74 | $1741.33 | $1592.27 |
| Shareholders' equity | ||||
| Retained earnings | -$1274.09 | -$1380.45 | $329.93 | $160.38 |
| Other shareholder equity | $15.65 | -$5.42 | -$6.17 | $13.11 |
| Total shareholder equity | $2997.06 | $5394.27 | $5189.84 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $3215.22 | $2953.12 | $2059.16 | $1514.77 |
| Short term investments | $442.67 | $287.54 | $290.75 | $288.37 |
| Net receivables | $743.56 | $644.88 | $616.3 | $481.99 |
| Inventory | $269.94 | $41.99 | $56.94 | $35.97 |
| Total current assets | $4645.4 | $4092.85 | $3118.67 | $2359.89 |
| Long term investments | $187.72 | $133.68 | $221.27 | $222.3 |
| Property, plant & equipment | $777.05 | $765.61 | $751.47 | $588.08 |
| Goodwill & intangible assets | $279.14 | $284.81 | $306.35 | $327.88 |
| Total noncurrent assets | $2136.7 | $1748.13 | $1814.68 | $1201.02 |
| Total investments | $630.38 | $421.22 | $512.02 | $510.67 |
| Total assets | $6782.11 | $5840.98 | $4933.35 | $3560.92 |
| Current liabilities | ||||
| Accounts payable | $109.6 | $277.55 | $172.11 | $98.77 |
| Deferred revenue | ||||
| Short long term debt | $3.44 | $3.18 | $2.63 | $2.28 |
| Total current liabilities | $1240.38 | $1157.08 | $854.31 | $631.2 |
| Long term debt | $29.16 | $30.08 | $31.63 | $32.57 |
| Total noncurrent liabilities | $351.89 | $313.79 | $309.04 | $318.45 |
| Total debt | $32.6 | $33.26 | $34.27 | $34.86 |
| Total liabilities | $1592.27 | $1470.87 | $1163.35 | $949.65 |
| Shareholders' equity | ||||
| Retained earnings | $160.38 | -$437.21 | -$777.87 | -$1726.45 |
| Other shareholder equity | $13.11 | $15.07 | -$19.45 | -$15.36 |
| Total shareholder equity | $5189.84 | $4370.12 | $3770 | $2611.27 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1137.87 | $1043.76 | $880.89 | $1013.34 |
| Cost of revenue | $76.63 | $60.96 | $69.75 | |
| Gross Profit | $1057.98 | $967.13 | $819.93 | $943.59 |
| Operating activities | ||||
| Research & development | $1138.38 | $429.26 | $444.49 | |
| Selling, general & administrative | $305.98 | $300.26 | $293.87 | |
| Total operating expenses | $888.48 | $1445.26 | $728.03 | $756.32 |
| Operating income | -$478.13 | $91.9 | $187.27 | |
| Income from continuing operations | ||||
| EBIT | -$389.12 | $236.59 | $271.76 | |
| Income tax expense | $50.07 | $54.82 | $66.61 | $69.88 |
| Interest expense | -$13.76 | $0.66 | $0.43 | $0.8 |
| Net income | ||||
| Net income | $106.46 | -$444.6 | $169.55 | $201.08 |
| Income (for common shares) | -$444.6 | $169.55 | $201.08 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3695.65 | $3394.64 | $2986.27 | $2666.7 |
| Cost of revenue | $254.99 | $207 | $150.99 | $131.33 |
| Gross Profit | $3440.66 | $3187.64 | $2835.28 | $2535.37 |
| Operating activities | ||||
| Research & development | $1627.59 | $1585.94 | $1458.18 | $2215.94 |
| Selling, general & administrative | $1161.29 | $1002.14 | $739.56 | $516.92 |
| Total operating expenses | $2820.13 | $2608.2 | $2234.76 | $2775.66 |
| Operating income | $620.52 | $579.44 | $600.52 | -$240.29 |
| Income from continuing operations | ||||
| EBIT | $836.77 | $531.78 | $572.35 | -$230.04 |
| Income tax expense | $236.62 | $188.46 | -$378.14 | $63.48 |
| Interest expense | $2.55 | $2.67 | $1.91 | $2.17 |
| Net income | ||||
| Net income | $597.6 | $340.66 | $948.58 | -$295.7 |
| Income (for common shares) | $597.6 | $340.66 | $948.58 | -$295.7 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$444.6 | $169.55 | $201.08 | |
| Operating activities | ||||
| Depreciation | $22.05 | $21.95 | $21.76 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $56.64 | $59.78 | $59.99 | |
| Total cash flows from operations | -$575.56 | $218.81 | $147.73 | |
| Investing activities | ||||
| Capital expenditures | -$54.14 | -$9.55 | -$2.27 | |
| Investments | $269.36 | -$63.56 | -$152.23 | |
| Total cash flows from investing | $178.98 | $213.82 | -$73.11 | -$154.5 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$1990.2 | $0.48 | $7.52 | |
| Net borrowings | -$0.91 | -$0.87 | -$0.84 | |
| Total cash flows from financing | -$2041.94 | -$1997.18 | -$12.41 | $0.35 |
| Effect of exchange rate | -$0.54 | $0.01 | -$0.68 | -$7.3 |
| Change in cash and equivalents | -$1909.38 | -$2358.91 | $132.61 | -$13.73 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $597.6 | $340.66 | $948.58 | -$295.7 |
| Operating activities | ||||
| Depreciation | $82.66 | $67.86 | $57.84 | $51.81 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $215.89 | $188.42 | $183.01 | $177.88 |
| Total cash flows from operations | $496.49 | $969.94 | $749.49 | -$124.6 |
| Investing activities | ||||
| Capital expenditures | -$32.49 | -$77.83 | -$181.01 | -$187.38 |
| Investments | -$160.19 | -$0.71 | -$26.69 | -$81.62 |
| Total cash flows from investing | -$207.68 | -$78.54 | -$207.7 | -$269 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $35.84 | $61.12 | $58.63 | $110.31 |
| Net borrowings | -$3.36 | -$2.86 | -$2.42 | -$0.84 |
| Total cash flows from financing | -$20.03 | -$0.79 | $6.18 | $71.71 |
| Effect of exchange rate | -$6.68 | $3.35 | -$3.57 | $2.95 |
| Change in cash and equivalents | $262.1 | $893.96 | $544.39 | -$318.94 |
News
Fundamentals
| Market cap | $13.57B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 192.80M |
| Revenue | $4.08B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $32.48M |
| Revenue Q/Q | 23.81% |
| Revenue Y/Y | 12.94% |
| P/E ratio | 417.80 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 3.33 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $0.17 |
|---|---|
| ROA | 0.55% |
| ROE | N/A |
| Debt/Equity | 0.31 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.87 |
| Quick ratio | 1.82 |